Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19 Aug '20 Aug '21 Aug '22
Equity (BVPS) 4.93
4.93
4.91
5.33
5.09
6.07
6.15
6.35
6.39
11.77
growth rate 0.0% -0.4% 8.6% -4.5% 19.3% 1.3% 3.3% 0.6% 84.2%
Earnings BIT 200.10
203.80
232.60
269.80
307.10
319.80
314.70
330.00
300.10
325.80
growth rate 1.9% 14.1% 16.0% 13.8% 4.1% -1.6% 4.9% -9.1% 8.6%
Avg.PE 38.44
47.32
49.28
44.40
44.40
44.40
34.43
growth rate 23.1% 4.1% -9.9% 0.0% 0.0% -22.5%
ROA 9.59
10.17
9.64
11.53
11.63
12.74
12.46
12.77
9.98
28.33
growth rate 6.1% -5.2% 19.6% 0.9% 9.5% -2.2% 2.5% -21.9% 183.9%
ROE 19.96
20.63
19.76
25.84
27.62
29.89
29.63
31.90
28.99
67.10
growth rate 3.4% -4.2% 30.8% 6.9% 8.2% -0.9% 7.7% -9.1% 131.5%
ROIC 12.72
13.07
12.34
14.65
14.82
16.03
15.74
16.50
12.82
35.15
growth rate 2.8% -5.6% 18.7% 1.2% 8.2% -1.8% 4.8% -22.3% 174.2%
Cur. Ratio 1.26
1.58
1.52
1.45
1.40
1.47
1.20
1.31
0.60
0.95
growth rate 25.4% -3.8% -4.6% -3.5% 5.0% -18.4% 9.2% -54.2% 58.3%
Quick Ratio 0.80
1.01
0.95
0.94
0.94
0.90
0.73
0.82
0.26
0.60
growth rate 26.3% -5.9% -1.1% 0.0% -4.3% -18.9% 12.3% -68.3% 130.8%
Leverage 2.05
2.01
2.09
2.40
2.35
2.35
2.41
2.58
3.20
1.92
growth rate -2.0% 4.0% 14.8% -2.1% 0.0% 2.6% 7.1% 24.0% -40.0%
Balance Sheet Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19 Aug '20 Aug '21 Aug '22
Acct.Receivable 110.00
113.50
121.60
137.50
158.50
170.60
185.20
215.60
173.80
227.20
222.10
growth rate 3.2% 7.1% 13.1% 15.3% 7.6% 8.6% 16.4% -19.4% 30.7% -2.2%
Acct.Payable 71.00
78.20
81.40
93.30
109.80
110.40
118.60
132.10
101.20
132.10
132.50
growth rate 10.1% 4.1% 14.6% 17.7% 0.6% 7.4% 11.4% -23.4% 30.5% 0.3%
Cur.Assets 260.00
285.40
284.60
328.70
407.90
387.60
411.30
474.00
607.10
429.30
498.40
growth rate 9.8% -0.3% 15.5% 24.1% -5.0% 6.1% 15.2% 28.1% -29.3% 16.1%
Total Assets 1,343.00
1,366.80
1,374.90
1,444.60
1,715.30
1,802.10
1,861.10
2,057.80
2,853.60
3,114.20
3,316.80
growth rate 1.8% 0.6% 5.1% 18.7% 5.1% 3.3% 10.6% 38.7% 9.1% 6.5%
Cash 61.00
77.50
57.60
76.40
119.80
73.00
69.10
87.40
96.20
55.10
82.80
growth rate 27.1% -25.7% 32.6% 56.8% -39.1% -5.3% 26.5% 10.1% -42.7% 50.3%
Inventory 83.00
87.60
99.70
108.30
120.10
135.20
146.90
160.00
122.30
133.90
180.60
growth rate 5.5% 13.8% 8.6% 10.9% 12.6% 8.7% 8.9% -23.6% 9.5% 34.9%
Cur.Liabilities 206.00
180.10
186.80
226.20
290.60
264.20
343.50
360.80
1,017.30
451.80
387.20
growth rate -12.6% 3.7% 21.1% 28.5% -9.1% 30.0% 5.0% 182.0% -55.6% -14.3%
Liabilities 682.00
686.10
718.10
843.80
985.00
1,033.60
1,089.50
1,260.60
1,960.60
1,488.10
1,492.90
growth rate 0.6% 4.7% 17.5% 16.7% 4.9% 5.4% 15.7% 55.5% -24.1% 0.3%
LT Debt 384.00
416.20
449.20
536.30
601.00
671.80
632.40
670.10
647.70
705.50
767.70
growth rate 8.4% 7.9% 19.4% 12.1% 11.8% -5.9% 6.0% -3.3% 8.9% 8.8%
Equity 656.80
600.80
730.30
768.50
771.60
797.20
893.00
1,626.10
1,823.90
growth rate -8.5% 21.6% 5.2% 0.4% 3.3% 12.0% 82.1% 12.2%
Common Shares 137.00
133.00
133.00
132.00
132.00
133.00
176.80
176.80
177.10
177.30
177.30
growth rate -2.9% 0.0% -0.8% 0.0% 0.8% 32.9% 0.0% 0.2% 0.1% 0.0%
Cash Flow Statement Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19 Aug '20 Aug '21 Aug '22
Capital Expenditures 41.00
52.70
50.60
55.10
59.70
90.90
88.80
97.70
98.30
135.70
119.30
growth rate 28.5% -4.0% 8.9% 8.4% 52.3% -2.3% 10.0% 0.6% 38.1% -12.1%
Cash Dividends 111.60
181.40
82.10
92.20
111.90
114.30
124.70
115.90
115.90
growth rate 62.5% -54.7% 12.3% 21.4% 2.1% 9.1% -7.1% 0.0%
Cash From OA 175.00
190.30
176.40
221.50
244.80
283.70
302.40
298.60
364.60
310.80
308.80
growth rate 8.7% -7.3% 25.6% 10.5% 15.9% 6.6% -1.3% 22.1% -14.8% -0.6%
FCF per Share 0.82
0.88
0.82
1.05
1.06
1.52
1.24
1.32
1.86
1.29
growth rate 7.3% -6.8% 28.1% 1.0% 43.4% -18.4% 6.5% 40.9% -30.7%
Sale Purchase of Stock 27.70
8.00
17.50
24.60
growth rate -71.1% 118.8% 40.6%
FCF 112.00
119.00
113.00
151.00
166.00
177.00
195.00
159.00
246.00
155.00
189.50
growth rate 6.3% -5.0% 33.6% 9.9% 6.6% 10.2% -18.5% 54.7% -37.0% 22.3%
Income Statement Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19 Aug '20 Aug '21 Aug '22
Sales 699.00
738.40
756.20
858.60
948.90
1,062.50
1,097.40
937.40
970.00
1,077.40
1,218.00
growth rate 5.6% 2.4% 13.5% 10.5% 12.0% 3.3% -14.6% 3.5% 11.1% 13.1%
Op.Income 131.00
200.10
203.80
232.60
269.80
307.10
319.80
314.70
330.00
300.10
325.80
growth rate 52.8% 1.9% 14.1% 16.0% 13.8% 4.1% -1.6% 4.9% -9.1% 8.6%
IBT 181.30
219.70
239.40
290.90
296.10
296.30
295.60
247.10
292.90
growth rate 21.2% 9.0% 21.5% 1.8% 0.1% -0.2% -16.4% 18.5%
Net Income 131.00
137.80
132.20
162.50
183.80
224.00
228.20
250.20
245.00
845.20
225.10
growth rate 5.2% -4.1% 22.9% 13.1% 21.9% 1.9% 9.6% -2.1% 245.0% -73.4%
EPS 0.95
1.04
1.00
1.23
1.40
1.68
1.73
1.90
1.86
6.41
growth rate 9.5% -3.9% 23.0% 13.8% 20.0% 3.0% 9.8% -2.1% 244.6%
Gross Profit 360.00
384.80
391.30
446.40
505.40
578.10
600.60
576.90
584.00
613.40
676.50
growth rate 6.9% 1.7% 14.1% 13.2% 14.4% 3.9% -4.0% 1.2% 5.0% 10.3%
R&D 43.20
51.00
59.70
69.80
73.40
70.40
73.10
88.10
96.80
growth rate 18.1% 17.1% 16.9% 5.2% -4.1% 3.8% 20.5% 9.9%

Quarterly Statements

Item Name Aug '21 Nov '21 Feb '22 May '22 Aug '22
Earnings BIT 86.20
65.50
84.10
85.20
93.10
growth rate -24.0% 28.4% 1.3% 9.3%
Balance Sheet Aug '21 Nov '21 Feb '22 May '22 Aug '22
Acct.Receivable 227.20
206.10
229.50
229.80
222.10
growth rate -9.3% 11.4% 0.1% -3.4%
Acct.Payable 132.10
95.50
107.40
108.40
132.50
growth rate -27.7% 12.5% 0.9% 22.2%
Cur.Assets 429.30
417.10
446.30
466.20
498.40
growth rate -2.8% 7.0% 4.5% 6.9%
Total Assets 3,114.20
3,110.20
3,142.90
3,205.00
3,316.80
growth rate -0.1% 1.1% 2.0% 3.5%
Cash 55.10
55.80
52.00
56.20
82.80
growth rate 1.3% -6.8% 8.1% 47.3%
Inventory 133.90
143.00
151.50
167.40
180.60
growth rate 6.8% 5.9% 10.5% 7.9%
Cur.Liabilities 451.80
431.90
422.70
356.40
387.20
growth rate -4.4% -2.1% -15.7% 8.6%
Liabilities 1,488.10
1,541.00
1,501.00
1,469.80
1,492.90
growth rate 3.6% -2.6% -2.1% 1.6%
LT Debt 705.50
865.60
834.30
866.70
767.80
growth rate 22.7% -3.6% 3.9% -11.4%
Equity 1,626.10
1,569.20
1,641.90
1,735.20
1,823.90
growth rate -3.5% 4.6% 5.7% 5.1%
Common Shares 177.30
177.30
177.20
177.20
177.30
growth rate 0.0% -0.1% 0.0% 0.1%
Cash Flow Statement Aug '21 Nov '21 Feb '22 May '22 Aug '22
Capital Expenditures 51.40
14.10
22.20
24.60
58.40
growth rate -72.6% 57.5% 10.8% 137.4%
Cash Dividends 115.90
115.90
growth rate 0.0%
Cash From OA 135.00
72.50
57.60
61.80
116.90
growth rate -46.3% -20.6% 7.3% 89.2%
Sale Purchase of Stock
growth rate
FCF 83.60
58.40
35.40
37.20
58.50
growth rate -30.1% -39.4% 5.1% 57.3%
Income Statement Aug '21 Nov '21 Feb '22 May '22 Aug '22
Sales 293.30
268.20
303.60
318.30
327.90
growth rate -8.6% 13.2% 4.8% 3.0%
Op.Income 86.20
65.50
84.10
85.20
93.10
growth rate -24.0% 28.4% 1.3% 9.3%
IBT 76.00
60.00
76.00
78.40
78.50
growth rate -21.1% 26.7% 3.2% 0.1%
Net Income 69.20
46.20
58.50
58.30
62.10
growth rate -33.2% 26.6% -0.3% 6.5%
Gross Profit 169.40
147.20
170.00
175.40
183.90
growth rate -13.1% 15.5% 3.2% 4.9%
R&D 23.20
23.50
24.70
23.30
23.20
growth rate 1.3% 5.1% -5.7% -0.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (69.24)

YOY Growth Grade:

C (56.48)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 34.06 34.06
EPS / Growth 1.75

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 22.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 22.1% 22.1% 22.1%
Future PE 0.01 26.10 26.10
Future EPS 12.91 12.91 12.91
Value Price
MOS %
0.03
83.30
83.30
MOS Price 0.02 41.65 41.65
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.